Glycyrrhizin prevents of lipopolysaccharide/D-galactosamine-induced liver injury through down-regulation of matrix metalloproteinase-9 in mice

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 1, 2008, Pages 91-97

  Abe, Kazuki ^a   Ikeda, Tadayuki ^b   Wake, Kenjiro ^b,c   Sato, Tetsuji ^b   Sato, Toshitsugu ^a   Inoue, Hideo ^a  

^a Minophagen Pharmaceutical Co   (Japan)

^b TSURUMI UNIVERSITY   (Japan)

^c Minophagen Pharmaceutical Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GALACTOSAMINE; GELATINASE B; GLYCYRRHIZIC ACID; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; PROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BAGG ALBINO MOUSE; CELL INFILTRATION; CHRONIC HEPATITIS; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; GLYCYRRHIZA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; LIVER; LIVER INJURY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PLANT ROOT; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; UPREGULATION;

ACUTE DISEASE; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GALACTOSAMINE; GLYCYRRHIZIC ACID; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 38349166780     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.1.0012     Document Type: Article

References (38)

1. Arase, Y., Ikeda, K., Murashima, N., Chayama, K., Tsubota, A., Koida, I., Suzuki, Y., Saitoh, S., Kobayashi, M., Kumada, H. (1997) The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 79: 1494-1500
2. Chosay, J. S., Essani, N. A., Dunn, C. J., Jaeschke, H. (1997) Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am. J. Physiol. 272: G1195-G1200
3. Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., Doerr, H.W. (2003) Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet 361: 2045-2046
4. Endo, Y., Shibazaki, M., Yamaguchi, K., Kai, K., Sugawara, S., Takada, H., Kikuchi, H., Kumagai, K. (1999) Enhancement by galactosamine of lipopolysaccharide (LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment. Br. J. Pharmacol. 128: 5-12
5. Ikeda, K., Arase, Y., Kobayashi, M., Saitoh, S., Someya, T., Hosaka, T., Sezaki, H., Akuta, N., Suzuki, Y., Suzuki, F., Kumada, H. (2006) A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients. Dig. Dis. Sci. 51: 603-609
6. Ito, Y., Abril, E. R., Bethea, N. W., McCuskey, R. S. (2005) Inhibition of matrix metalloproteinases minimizes hepatic microvascular injury in response to acetaminophen in mice. Toxicol. Sci. 83: 190-196
7. Ito, Y., Abril, E. R., Bethea, N. W., McCuskey, M. K., Cover, C., Jaeschke, H., McCuskey, R. S. (2006) Mechanisms and pathophysiological implications of sinusoidal endothelial cell gap formation following treatment with galactosamine/endotoxin in mice. Am. J. Physiol. Gastrointest. Liver. Physiol. 291: G211-218
8. Itokazu, Y., Segawa, Y., Omata, T., Inoue, N., Tsuzuike, N., Nagasawa, M., Nishioka, H., Kobayashi, T., Nakano, Y., Kanda, T. (2000) Effects of ZNC-2381, a new oral compound, on several hepatic injury models and on hepatocellular apoptosis in mice and rat. J. Pharm. Pharmacol. 52: 531-538
9. Kimura, M., Inoue, H., Hirabayashi, K., Natsume, H., Ogihara, M. (2001) Glycyrrhizin and some analogues induce growth of primary cultured adult rat hepatocytes via epidermal growth factor receptors. Eur. J. Pharmacol. 431: 151-161
10. Knittel, T., Mehde, M., Kobold, D., Saile, B., Dinter, C. Ramadori, G. (1999) Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: Regulation by TNF-α and TGF-β1. J. Hepatol. 30: 48-60
11. Leist, M., Gantner, F., Bohlinger, I., Tiegs, G., Germann, P. G., Wendel, A. (1995) Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 146: 1220-1234
12. Morikawa, A., Sugiyama, T., Kato, Y., Koide, N., Jiang, G., Takahashi, K., Tamada, Y., Yokochi, T. (1996) Apoptotic cell death in the response of D-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model. Infect. Immun. 64: 734-738
13. Nakanishi, K., Yoshimoto, T., Tsutsui, H., Okamura, H. (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19: 423-474
14. Nagai, T., Egashira, T., Yamanaka, Y., Kohno, M. (1991) The protective effect of glycyrrhizin against injury of the liver caused by ischemia-reperfusion. Arc. Environ. Contam. Toxicol. 20: 432-436
15. Nose, M., Ito, M., Kamimura, K., Shimizu, M., Ogihara, Y. (1994) A comparison of the antihepatotoxic activity between glycyrrhizin and glycyrrhetinic acid. Planta Med. 60: 136-139
16. Nowak, M., Gaines, G. C., Rosenberg. J., Minter, R., Bahjat, F. R., Rectenwald, J., MacKay, S. L., Edwards, C. K., Moldawer, L. L. (2000) LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278: 1202-1209
17. Ohuchi, K., Kamada, Y., Levine, L., Tsurufuji, S. (1981) Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats. Prostaglandins Med. 7: 457-463
18. Okamoto, T. (2000) The protective effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice. Eur. J. Pharmacol. 387: 229-232
19. Okamoto, T., Kanda, T. (1999) Glycyrrhizin protects mice from concanavalin A-induced hepatitis without affecting cytokine expression. Int. J. Mol. Med. 4: 149-152
20. Okimasu, E., Moromizato, Y., Watanabe, S., Sasaki, J., Shiraishi, N., Morimoto, Y. M., Miyahara, M., Utsumi, K. (1983) Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug. Acta Med. Okayama 37: 385-391
21. Pagenstecher, A., Stalder, A. K., Kincaid, C. L., Volk, B., Campbell, I. L. (2000) Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice. Am. J. Pathol. 157: 197-210
22. Pugin, J., Widmer, M. C., Kossodo, S., Liang, C. M., Preas, H. L., Suffredini, A. F. (1999) Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am. J. Respir. Cell. Mol. Biol. 20: 458-464
23. Sakano, Y., Takeda, K., Tsutsui, H., Kaisho, T., Nomura, F., Okamura, H., Nakanishi, K., Akira, S. (1999) IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. Int. Immunol. 11: 471-480
24. Sass, G., Heinlein, S., Agli, A., Bang, R., Schumann, J., Tiegs, G. (2002) Cytokine expression in three mouse model of experimental hepatitis. Cytokine 19: 115-120
25. Shibayama, Y. (1989) Prevention of hepatotoxic responses to chemicals by glycyrrhizin in rats. Exp. Mol. Pathol. 51: 48-55
26. Shiki, Y., Shirai, K., Saito, Y., Yoshida, S., Mori, Y., Wakashin, M. (1992) Effects of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody. J. Gastroenterol. Hepatol. 7: 12-16
27. Shin, Y. W., Bae, E. A., Lee, B., Lee, S. H., Kim, J. A., Kim, Y. S., Kim, D. H. (2007) In vitro and in vivo antiallergic effects of glycyrrhiza glabra and its components. Planta Med. 73: 257-261
28. Tiegs, G. (1994) Immunotoxicology of host-response-mediated experimental liver injury. J. Hepatol. 21: 890-903
29. Tiegs, G., Wolter, M., Wendel, A. (1989) Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem. Pharmacol. 38: 627-631
30. Vaillant, B., Chiaramonte, M. G., Cheever, A. W., Soloway, P. D., Wynn, T. A. (2001) Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J. Immunol. 167: 7017-7026
31. van Rossum, T. G., Vulto, A. G., Hop, W. C., Brouwer, J. T., Niesters, H. G., Schalm, S. W. (1999a) Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial. J. Gastroenterol. Hepatol. 14: 1093-1099
32. van Rossum, T. G., Vulto, A. G., Hop, W. C., Schalm, S. W. (1999b) Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection. Clin. Ther. 21: 2080-2090
33. van Rossum, T. G., Vulto, A. G., Hop, W. C., Schalm, S. W. (2001) Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C. Am. J. Gastroenterol. 96: 2432-2437
34. Visse, R., Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92: 827-839
35. Wielockx, B., Lannoy, K., Shapiro, S. D., Itoh, T., Itohara, S., Vandekerckhove, J., Libert, C. (2001) Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat. Med. 7: 1202-1208
36. Xiong, Q., Hase, K., Tezuka, Y., Namba, T., Kadota, S. (1999) Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccharide-induced liver injury. Life. Sci. 65: 421-430
37. Yoshida, T., Abe, K., Ikeda, T., Matsushita, T., Wake, K., Sato, T., Sato, T., Inoue, H. (2007) Inhibitory effect of glycyrrhizin on lipopolysaccharide and D-galactosamine-induced mouse liver injury. Eur. J. Pharmacol. 576: 136-142
38. Yumoto, E., Higashi, T., Nouso, K., Nakatsukasa, H., Fujiwara, K., Hanafusa, T., Yumoto, Y., Tanimoto, T., Kurimoto, M., Tanaka, N., Tsuji, T. (2002) Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J. Gastroenterol. Hepatol. 17: 285-294